← Back to Search

Walking Adjustments for Stroke Recovery

N/A
Recruiting
Research Sponsored by Chapman University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
For stroke survivors: Chronic hemiparesis (time since stroke > 6 months) caused by a single documented stroke event
For stroke survivors: Ability to walk over ground independently or with the use of a cane
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured day 1 and day 2 of the study while individuals are walking on the treadmill. first and last 10 strides on day 1 and day 2 of testing
Awards & highlights

Study Summary

This trial will evaluate how people post-stroke can modify their walking patterns with feedback and changes in environment, to promote recovery of walking function.

Who is the study for?
This trial is for stroke survivors with chronic hemiparesis who can walk on a treadmill for 2 minutes and over ground independently or with a cane. They must not have used a split-belt treadmill before, have no other neurological disorders or orthopedic conditions affecting their walk, and must have normal vision. Neurotypical adults without walking impairments, neurological disorders, severe head trauma in the last two years, or prior split-belt treadmill experience can also participate.Check my eligibility
What is being tested?
The study tests how stroke survivors adjust their walking patterns using biofeedback (explicit adjustments) versus adapting naturally to changes like those introduced by a split belt treadmill (implicit adjustments). It aims to understand muscle activation differences between these methods to improve post-stroke walking rehabilitation.See study design
What are the potential side effects?
While specific side effects are not detailed in this summary, participants may experience fatigue from physical activity or discomfort associated with adjusting to different walking patterns during the use of biofeedback devices and the split belt treadmill.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have had weakness on one side of my body for over 6 months due to a stroke.
Select...
I can walk on my own or with a cane after having a stroke.
Select...
I am a stroke survivor and can walk without any other health issues affecting me.
Select...
I have never walked on a split-belt treadmill before.
Select...
I have never had a neurological disorder or severe head injury.
Select...
I have never walked on a split-belt treadmill before.
Select...
I haven't had any injuries or conditions in the past 2 years that stopped me from walking.
Select...
I can walk on a treadmill for 2 minutes without stopping.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured day 1 and day 2 of the study while individuals are walking on the treadmill. first and last 10 strides on day 1 and day 2 of testing
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured day 1 and day 2 of the study while individuals are walking on the treadmill. first and last 10 strides on day 1 and day 2 of testing for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
VAF1 - variance accounted for in a single muscle activation module
walkDMC - walking Dynamic Motor Control Index
Secondary outcome measures
Compensation measures - hip circumduction
Compensation measures - hip hiking
Compensation measures - overreliance on the non-paretic extremity to generate propulsion
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Stroke participantsExperimental Treatment2 Interventions
Researchers will assess muscle control in participants post-stroke during different types of walking modifications
Group II: Neurotypical participantsActive Control2 Interventions
Researchers will compare muscle control to neurotypical participants during the same types of walking modifications to assess stroke-induced changes in muscle control vs. intervention-induced changes in muscle control
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Biofeedback
2016
Completed Phase 4
~1280
Split belt treadmill
2012
N/A
~40

Find a Location

Who is running the clinical trial?

Chapman UniversityLead Sponsor
6 Previous Clinical Trials
1,346 Total Patients Enrolled
1 Trials studying Stroke
28 Patients Enrolled for Stroke
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
1,965 Previous Clinical Trials
2,672,762 Total Patients Enrolled
79 Trials studying Stroke
5,352 Patients Enrolled for Stroke

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Am I eligible to enroll in this scientific experiment?

"Aspiring participants of this trial must have a history of stroke and be between 18 to 90 years old. In total, 35 individuals are needed for the endeavour."

Answered by AI

Does the age criterion for this trial extend past sixty years of age?

"To meet the qualifications for this clinical trial, prospective participants must fall between 18 and 90 years of age."

Answered by AI

Is there still availability for individuals to join this clinical trial?

"Affirmative. Examining the information posted on clinicaltrials.gov, it is apparent that this medical trial is recruiting participants right now; moreover, it was first advertised on September 7th 2023 and most recently updated on 11th of the same month. A total of 35 patients are needed to be recruited from 1 particular site."

Answered by AI

What is the total subject count for this medical research endeavor?

"Affirmative. Clinicaltrials.gov displays that this experiment, which was published on September 7th 2023, is actively enrolling individuals. Approximately 35 people need to be recruited from a single trial site."

Answered by AI

What objectives are this inquiry aiming to fulfill?

"This clinical trial's primary objective is to evaluate the Dynamic Motor Control Index (DMC) of participants on Day 1 and 2 while they are walking on a treadmill. Secondary outcomes that will be monitored include hip hiking, hip circumduction, as well as if individuals have an over-reliance on their non-paretic extremity for propulsion. All measurements will be taken in degrees or percentages accordingly."

Answered by AI
~21 spots leftby Mar 2025